J L Bulliard1, B Cox. 1. Hugh Adam Cancer Epidemiology Unit, Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, New Zealand. Jean-Luc.Bulliard@inst.hospvd.ch
Abstract
BACKGROUND: Site-specific trend analysis is probably the most effective method available for assessing how the long-term trend in melanoma rates relates to changes in sun exposure and behaviour. New Zealand has very high incidence of and mortality from melanoma and the fraction of melanoma cases and deaths with a site specified has been comparatively high. METHODS: Trends in incidence and mortality from melanoma in New Zealand were analysed between 1969 and 1993, by sex and body site. A graphical representation of the trend by birth-cohort and age-period-cohort modelling were used. RESULTS: For all sites combined, the annual increase in incidence was 6.7% (95% CI : 6.3-7.1%) in men and 3.1% (95% CI : 2.3-3.7%) in women. The increase was significantly greater at each site for males. The largest increases occurred for the upper limbs in males (7.3% a year) and the trunk in females (3.8% a year). Incidence rates slowed appreciably in the later years (currently about 26/100 000 for each sex) and no further increase in lifetime risk of melanoma was observed among post World War II generations. Mortality trends paralleled those for incidence with a 25-year gap, with a more modest rate of increase (2-3% per annum for each sex), essentially due to the increased risk among generations born up to 1919 or 1924. Age-standardized death rates have now stabilized in New Zealand at about 5.5/100 000 (men) and 3.2/100 000 (women). Trends between cohorts were the most marked for sites with a likely intermittent pattern of exposure, and were consistent overall for the trunk and the limbs. CONCLUSIONS: Results support the hypothesis that changes in lifestyle factors resulted in a pattern of carcinogenic exposures that explains both the upsurge in melanoma in the last few decades and the current levelling off in incidence.
BACKGROUND: Site-specific trend analysis is probably the most effective method available for assessing how the long-term trend in melanoma rates relates to changes in sun exposure and behaviour. New Zealand has very high incidence of and mortality from melanoma and the fraction of melanoma cases and deaths with a site specified has been comparatively high. METHODS: Trends in incidence and mortality from melanoma in New Zealand were analysed between 1969 and 1993, by sex and body site. A graphical representation of the trend by birth-cohort and age-period-cohort modelling were used. RESULTS: For all sites combined, the annual increase in incidence was 6.7% (95% CI : 6.3-7.1%) in men and 3.1% (95% CI : 2.3-3.7%) in women. The increase was significantly greater at each site for males. The largest increases occurred for the upper limbs in males (7.3% a year) and the trunk in females (3.8% a year). Incidence rates slowed appreciably in the later years (currently about 26/100 000 for each sex) and no further increase in lifetime risk of melanoma was observed among post World War II generations. Mortality trends paralleled those for incidence with a 25-year gap, with a more modest rate of increase (2-3% per annum for each sex), essentially due to the increased risk among generations born up to 1919 or 1924. Age-standardized death rates have now stabilized in New Zealand at about 5.5/100 000 (men) and 3.2/100 000 (women). Trends between cohorts were the most marked for sites with a likely intermittent pattern of exposure, and were consistent overall for the trunk and the limbs. CONCLUSIONS: Results support the hypothesis that changes in lifestyle factors resulted in a pattern of carcinogenic exposures that explains both the upsurge in melanoma in the last few decades and the current levelling off in incidence.
Authors: Garrett C Lowe; Alexandra Saavedra; Kurtis B Reed; Ana I Velazquez; Roxana S Dronca; Svetomir N Markovic; Christine M Lohse; Jerry D Brewer Journal: Mayo Clin Proc Date: 2014-01 Impact factor: 7.616
Authors: Thomas R Fears; Richard W Sagebiel; Allan Halpern; David E Elder; Elizabeth A Holly; Dupont Guerry; Margaret A Tucker Journal: Pigment Cell Melanoma Res Date: 2011-03-29 Impact factor: 4.693
Authors: Porcia T Bradford; William F Anderson; Mark P Purdue; Alisa M Goldstein; Margaret A Tucker Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-09 Impact factor: 4.254
Authors: Alan C Geller; Richard W Clapp; Arthur J Sober; Lou Gonsalves; Lloyd Mueller; Cindy L Christiansen; Waqas Shaikh; Donald R Miller Journal: J Clin Oncol Date: 2013-09-16 Impact factor: 44.544
Authors: Catherine M Olsen; Michael S Zens; Therese A Stukel; Carlotta Sacerdote; Yu-Mei Chang; Bruce K Armstrong; Veronique Bataille; Marianne Berwick; J Mark Elwood; Elizabeth A Holly; Connie Kirkpatrick; Thomas Mack; Julia Newton Bishop; Anne Østerlind; Anthony J Swerdlow; Roberto Zanetti; Adèle C Green; Margaret R Karagas; David C Whiteman Journal: Int J Cancer Date: 2009-02-15 Impact factor: 7.396